This is a Validated Antibody Database (VAD) review about chimpanzee ITGAX, based on 38 published articles (read how Labome selects the articles), using ITGAX antibody in all methods. It is aimed to help Labome visitors find the most suited ITGAX antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
BioLegend
mouse monoclonal (3.9)
  • flow cytometry; human; loading ...; fig 1a
BioLegend ITGAX antibody (BioLegend, 3.9) was used in flow cytometry on human samples (fig 1a). Am J Respir Crit Care Med (2019) ncbi
mouse monoclonal (3.9)
  • flow cytometry; rhesus macaque; loading ...; fig 2d
BioLegend ITGAX antibody (BioLegend, 3.9) was used in flow cytometry on rhesus macaque samples (fig 2d). J Virol (2019) ncbi
mouse monoclonal (3.9)
  • flow cytometry; human; loading ...; fig s3k
BioLegend ITGAX antibody (Biolegend, 301638) was used in flow cytometry on human samples (fig s3k). Cell Rep (2018) ncbi
mouse monoclonal (3.9)
  • flow cytometry; human; loading ...; fig 1c
BioLegend ITGAX antibody (BioLegend, 301637) was used in flow cytometry on human samples (fig 1c). J Exp Med (2018) ncbi
mouse monoclonal (3.9)
  • flow cytometry; human; loading ...; fig 1a
BioLegend ITGAX antibody (Biolegend, 3.9) was used in flow cytometry on human samples (fig 1a). J Immunol (2018) ncbi
mouse monoclonal (3.9)
  • flow cytometry; human; loading ...; fig s4d
BioLegend ITGAX antibody (Biolegend, 301630) was used in flow cytometry on human samples (fig s4d). J Clin Invest (2018) ncbi
mouse monoclonal (3.9)
  • flow cytometry; human; loading ...; fig 1a
BioLegend ITGAX antibody (BioLegend, 301609) was used in flow cytometry on human samples (fig 1a). Cell Rep (2018) ncbi
mouse monoclonal (3.9)
  • flow cytometry; human; 1:100; loading ...; fig s2a
BioLegend ITGAX antibody (BioLegend, 301619) was used in flow cytometry on human samples at 1:100 (fig s2a). Nat Commun (2018) ncbi
mouse monoclonal (3.9)
  • flow cytometry; human; loading ...; fig s1
BioLegend ITGAX antibody (BioLegend, 3.9) was used in flow cytometry on human samples (fig s1). J Biol Chem (2018) ncbi
mouse monoclonal (3.9)
  • blocking or activating experiments; human; fig 4a
  • flow cytometry; human; fig 1a
BioLegend ITGAX antibody (BioLegend, 301616) was used in blocking or activating experiments on human samples (fig 4a) and in flow cytometry on human samples (fig 1a). J Cell Sci (2018) ncbi
mouse monoclonal (3.9)
  • flow cytometry; human; loading ...; fig s14b
In order to map the lineage of human dendritic cells, BioLegend ITGAX antibody (BioLegend, 3,9) was used in flow cytometry on human samples (fig s14b). Science (2017) ncbi
mouse monoclonal (3.9)
  • flow cytometry; human; loading ...
In order to investigate the involvement of the TRIF pathway against the infection of Zika, Chikungunya, and Dengue viruses, BioLegend ITGAX antibody (BioLegend, 3.9) was used in flow cytometry on human samples . MBio (2017) ncbi
mouse monoclonal (3.9)
  • flow cytometry; human; loading ...; fig 1e
BioLegend ITGAX antibody (Biolegend, 3.9) was used in flow cytometry on human samples (fig 1e). Nat Med (2017) ncbi
mouse monoclonal (3.9)
  • flow cytometry; human; loading ...; fig 4b
BioLegend ITGAX antibody (BioLegend, 301608) was used in flow cytometry on human samples (fig 4b). PLoS ONE (2016) ncbi
mouse monoclonal (3.9)
  • flow cytometry; human; loading ...
In order to establish the T Cell receptor-inducible costimulator as a promising target for direct T regulatory cell-targeting therapeutic agents for gastric cancer, BioLegend ITGAX antibody (BioLegend, 3.9) was used in flow cytometry on human samples . Int J Cancer (2017) ncbi
mouse monoclonal (3.9)
  • flow cytometry; human; loading ...
In order to assess the role of C1q in downregulating allergic inflammation, BioLegend ITGAX antibody (Biolegend, 3.9) was used in flow cytometry on human samples . Mucosal Immunol (2017) ncbi
mouse monoclonal (3.9)
  • blocking or activating experiments; human; loading ...; fig 5c
In order to determine the contribution of CD16 positive monocytes to antibody-dependent cellular cytotoxicity, BioLegend ITGAX antibody (BioLegend, 3.9) was used in blocking or activating experiments on human samples (fig 5c). Sci Rep (2016) ncbi
mouse monoclonal (3.9)
  • flow cytometry; human; fig 7b
BioLegend ITGAX antibody (BioLegend, 301613) was used in flow cytometry on human samples (fig 7b). J Exp Clin Cancer Res (2016) ncbi
mouse monoclonal (3.9)
  • flow cytometry; human; fig 6a
BioLegend ITGAX antibody (BioLegend, 3.9) was used in flow cytometry on human samples (fig 6a). J Biol Chem (2016) ncbi
mouse monoclonal (3.9)
  • flow cytometry; African green monkey; loading ...; fig 2a
In order to discuss the use of flow cytometry to examine common marmosets, BioLegend ITGAX antibody (BioLegend, 3.9) was used in flow cytometry on African green monkey samples (fig 2a). J Med Primatol (2016) ncbi
mouse monoclonal (3.9)
  • flow cytometry; human; fig s1e
  • immunocytochemistry; human
In order to discuss the impact of filaggrin mutations on the development of atopic dermatitis, BioLegend ITGAX antibody (BioLegend, 3.9) was used in flow cytometry on human samples (fig s1e) and in immunocytochemistry on human samples . J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (3.9)
  • flow cytometry; human; loading ...; fig 1a
In order to characterize innate lymphoid cell subpopulations isolated from patients with systemic sclerosis, BioLegend ITGAX antibody (biolegend, 3.9) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (3.9)
  • flow cytometry; human
BioLegend ITGAX antibody (Biolegend, 301604) was used in flow cytometry on human samples . Scand J Immunol (2015) ncbi
mouse monoclonal (3.9)
  • flow cytometry; mouse; fig s4
BioLegend ITGAX antibody (Biolegend, 301628) was used in flow cytometry on mouse samples (fig s4). Proc Natl Acad Sci U S A (2015) ncbi
mouse monoclonal (3.9)
  • flow cytometry; human; loading ...; fig 9a
In order to explore a macrophage TLR9-BTK-calcineurin-NFAT signaling pathway involved in impair fungal immunity, BioLegend ITGAX antibody (Biolegend, 301607) was used in flow cytometry on human samples (fig 9a). EMBO Mol Med (2015) ncbi
mouse monoclonal (3.9)
  • flow cytometry; human
BioLegend ITGAX antibody (Biolegend, 3.9) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (3.9)
  • flow cytometry; human
BioLegend ITGAX antibody (Biolegend, 3.9) was used in flow cytometry on human samples . Hepatology (2015) ncbi
mouse monoclonal (3.9)
  • flow cytometry; human
BioLegend ITGAX antibody (BioLegend, 3.9) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (3.9)
  • flow cytometry; human
BioLegend ITGAX antibody (BioLegend, 3.9) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (3.9)
  • flow cytometry; human
BioLegend ITGAX antibody (Biolegend, 3.9) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (3.9)
  • blocking or activating experiments; human
  • flow cytometry; human
BioLegend ITGAX antibody (Biolegend, 3.9) was used in blocking or activating experiments on human samples and in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (3.9)
  • flow cytometry; human
BioLegend ITGAX antibody (BioLegend, 3.9) was used in flow cytometry on human samples . Clin Cancer Res (2014) ncbi
mouse monoclonal (3.9)
  • flow cytometry; human
BioLegend ITGAX antibody (BioLegend, 3.9) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (3.9)
  • flow cytometry; human
In order to examine various DC after flu vaccination, BioLegend ITGAX antibody (Biolegend, 3.9) was used in flow cytometry on human samples . Immunol Invest (2014) ncbi
mouse monoclonal (3.9)
  • flow cytometry; human
In order to determine the presence, frequency, association to other immune parameters, and functional properties of circulating CD14(+) cells lacking HLA-DR expression in patients with untreated chronic lymphocytic leukemia, BioLegend ITGAX antibody (Biolegend, 3.9) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (3.9)
  • flow cytometry; human
BioLegend ITGAX antibody (BioLegend, 3.9) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (3.9)
  • flow cytometry; human
In order to elucidate the immunological pathways that lead to obesity-associated asthma, BioLegend ITGAX antibody (BioLegend, 301604) was used in flow cytometry on human samples . Nat Med (2014) ncbi
mouse monoclonal (3.9)
  • flow cytometry; human
BioLegend ITGAX antibody (Biolegend, (clone 3.9) was used in flow cytometry on human samples . J Immunol Methods (2009) ncbi
Articles Reviewed
  1. Allden S, Ogger P, Ghai P, McErlean P, Hewitt R, Toshner R, et al. The Transferrin Receptor CD71 Delineates Functionally Distinct Airway Macrophage Subsets during Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2019;: pubmed publisher
  2. Chea L, Wyatt L, Gangadhara S, Moss B, Amara R. Novel Modified Vaccinia Virus Ankara Vector Expressing Anti-apoptotic Gene B13R Delays Apoptosis and Enhances Humoral Responses. J Virol. 2019;93: pubmed publisher
  3. Ding L, Kim H, Wang Q, Kearns M, Jiang T, Ohlson C, et al. PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer. Cell Rep. 2018;25:2972-2980.e5 pubmed publisher
  4. Kelly A, Günaltay S, McEntee C, Shuttleworth E, Smedley C, Houston S, et al. Human monocytes and macrophages regulate immune tolerance via integrin αvβ8-mediated TGFβ activation. J Exp Med. 2018;215:2725-2736 pubmed publisher
  5. Walwyn Brown K, Guldevall K, Saeed M, Pende D, Önfelt B, MacDonald A, et al. Human NK Cells Lyse Th2-Polarizing Dendritic Cells via NKp30 and DNAM-1. J Immunol. 2018;201:2028-2041 pubmed publisher
  6. Burton A, Pallett L, McCoy L, Suveizdyte K, Amin O, Swadling L, et al. Circulating and intrahepatic antiviral B cells are defective in hepatitis B. J Clin Invest. 2018;128:4588-4603 pubmed publisher
  7. Zhao Y, Harrison D, Song Y, Ji J, Huang J, Hui E. Antigen-Presenting Cell-Intrinsic PD-1 Neutralizes PD-L1 in cis to Attenuate PD-1 Signaling in T Cells. Cell Rep. 2018;24:379-390.e6 pubmed publisher
  8. Murakami T, Kim J, Li Y, Green G, Shikanov A, Ono A. Secondary lymphoid organ fibroblastic reticular cells mediate trans-infection of HIV-1 via CD44-hyaluronan interactions. Nat Commun. 2018;9:2436 pubmed publisher
  9. Melo Gonzalez F, Fenton T, Forss C, Smedley C, Goenka A, MacDonald A, et al. Intestinal mucin activates human dendritic cells and IL-8 production in a glycan-specific manner. J Biol Chem. 2018;293:8543-8553 pubmed publisher
  10. Buffone A, Anderson N, Hammer D. Migration against the direction of flow is LFA-1-dependent in human hematopoietic stem and progenitor cells. J Cell Sci. 2018;131: pubmed publisher
  11. See P, Dutertre C, Chen J, Günther P, McGovern N, Irac S, et al. Mapping the human DC lineage through the integration of high-dimensional techniques. Science. 2017;356: pubmed publisher
  12. Pryke K, Abraham J, Sali T, Gall B, Archer I, Liu A, et al. A Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory to Replication of Zika, Chikungunya, and Dengue Viruses. MBio. 2017;8: pubmed publisher
  13. Daley D, Mani V, Mohan N, Akkad N, Ochi A, Heindel D, et al. Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance. Nat Med. 2017;23:556-567 pubmed publisher
  14. Assadi G, Vesterlund L, Bonfiglio F, Mazzurana L, Cordeddu L, Schepis D, et al. Functional Analyses of the Crohn's Disease Risk Gene LACC1. PLoS ONE. 2016;11:e0168276 pubmed publisher
  15. Nagase H, Takeoka T, Urakawa S, Morimoto Okazawa A, Kawashima A, Iwahori K, et al. ICOS+ Foxp3+ TILs in gastric cancer are prognostic markers and effector regulatory T cells associated with Helicobacter pylori. Int J Cancer. 2017;140:686-695 pubmed publisher
  16. Mascarell L, Airouche S, Berjont N, Gary C, Gueguen C, Fourcade G, et al. The regulatory dendritic cell marker C1q is a potent inhibitor of allergic inflammation. Mucosal Immunol. 2017;10:695-704 pubmed publisher
  17. Yeap W, Wong K, Shimasaki N, Teo E, Quek J, Yong H, et al. CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes. Sci Rep. 2016;6:34310 pubmed publisher
  18. Takeda Y, Azuma M, Matsumoto M, Seya T. Tumoricidal efficacy coincides with CD11c up-regulation in antigen-specific CD8(+) T cells during vaccine immunotherapy. J Exp Clin Cancer Res. 2016;35:143 pubmed publisher
  19. Wittmann A, Lamprinaki D, Bowles K, Katzenellenbogen E, Knirel Y, Whitfield C, et al. Dectin-2 Recognizes Mannosylated O-antigens of Human Opportunistic Pathogens and Augments Lipopolysaccharide Activation of Myeloid Cells. J Biol Chem. 2016;291:17629-38 pubmed publisher
  20. Neumann B, Shi T, Gan L, Klippert A, Daskalaki M, Stolte Leeb N, et al. Comprehensive panel of cross-reacting monoclonal antibodies for analysis of different immune cells and their distribution in the common marmoset (Callithrix jacchus). J Med Primatol. 2016;45:139-46 pubmed publisher
  21. Leitch C, Natafji E, Yu C, Abdul Ghaffar S, Madarasingha N, Venables Z, et al. Filaggrin-null mutations are associated with increased maturation markers on Langerhans cells. J Allergy Clin Immunol. 2016;138:482-490.e7 pubmed publisher
  22. Roan F, Stoklasek T, Whalen E, Molitor J, Bluestone J, Buckner J, et al. CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis. J Immunol. 2016;196:2051-2062 pubmed publisher
  23. Dyring Andersen B, Bonefeld C, Bzorek M, Løvendorf M, Lauritsen J, Skov L, et al. The Vitamin D Analogue Calcipotriol Reduces the Frequency of CD8+ IL-17+ T Cells in Psoriasis Lesions. Scand J Immunol. 2015;82:84-91 pubmed publisher
  24. Cheah M, Chen J, Sahoo D, Contreras Trujillo H, Volkmer A, Scheeren F, et al. CD14-expressing cancer cells establish the inflammatory and proliferative tumor microenvironment in bladder cancer. Proc Natl Acad Sci U S A. 2015;112:4725-30 pubmed publisher
  25. Herbst S, Shah A, Mazon Moya M, Marzola V, Jensen B, Reed A, et al. Phagocytosis-dependent activation of a TLR9-BTK-calcineurin-NFAT pathway co-ordinates innate immunity to Aspergillus fumigatus. EMBO Mol Med. 2015;7:240-58 pubmed publisher
  26. Freeman A, Bridge J, Maruthayanar P, Overgaard N, Jung J, Simpson F, et al. Comparative immune phenotypic analysis of cutaneous Squamous Cell Carcinoma and Intraepidermal Carcinoma in immune-competent individuals: proportional representation of CD8+ T-cells but not FoxP3+ Regulatory T-cells is associated with disease stage. PLoS ONE. 2014;9:e110928 pubmed publisher
  27. Velazquez V, Uebelhoer L, Thapa M, Ibegbu C, Courtney C, Bosinger S, et al. Systems biological analyses reveal the hepatitis C virus (HCV)-specific regulation of hematopoietic development. Hepatology. 2015;61:843-56 pubmed publisher
  28. Škrnjug I, Guzmán C, Rueckert C, Ruecker C. Cyclic GMP-AMP displays mucosal adjuvant activity in mice. PLoS ONE. 2014;9:e110150 pubmed publisher
  29. Al Barwani F, Young S, Baird M, Larsen D, Ward V. Mannosylation of virus-like particles enhances internalization by antigen presenting cells. PLoS ONE. 2014;9:e104523 pubmed publisher
  30. Jin J, Zhang W, Wong K, Kwak M, van Driel I, Yu Q. Inhibition of breast cancer resistance protein (ABCG2) in human myeloid dendritic cells induces potent tolerogenic functions during LPS stimulation. PLoS ONE. 2014;9:e104753 pubmed publisher
  31. Marinho C, Azeredo E, Torrentes Carvalho A, Marins Dos Santos A, Kubelka C, de Souza L, et al. Down-regulation of complement receptors on the surface of host monocyte even as in vitro complement pathway blocking interferes in dengue infection. PLoS ONE. 2014;9:e102014 pubmed publisher
  32. Koido S, Homma S, Okamoto M, Takakura K, Mori M, Yoshizaki S, et al. Treatment with chemotherapy and dendritic cells pulsed with multiple Wilms' tumor 1 (WT1)-specific MHC class I/II-restricted epitopes for pancreatic cancer. Clin Cancer Res. 2014;20:4228-39 pubmed publisher
  33. Kawasaki N, Rillahan C, Cheng T, Van Rhijn I, Macauley M, Moody D, et al. Targeted delivery of mycobacterial antigens to human dendritic cells via Siglec-7 induces robust T cell activation. J Immunol. 2014;193:1560-6 pubmed publisher
  34. Kobie J, Treanor J, Ritchlin C. Transient decrease in human peripheral blood myeloid dendritic cells following influenza vaccination correlates with induction of serum antibody. Immunol Invest. 2014;43:606-15 pubmed publisher
  35. Jitschin R, Braun M, Büttner M, Dettmer Wilde K, Bricks J, Berger J, et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood. 2014;124:750-60 pubmed publisher
  36. Skrnjug I, Rueckert C, Libanova R, Lienenklaus S, Weiss S, Guzman C. The mucosal adjuvant cyclic di-AMP exerts immune stimulatory effects on dendritic cells and macrophages. PLoS ONE. 2014;9:e95728 pubmed publisher
  37. Kim H, Lee H, Chang Y, Pichavant M, Shore S, Fitzgerald K, et al. Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat Med. 2014;20:54-61 pubmed publisher
  38. Wang J, Kobie J, Zhang L, Cochran M, Mosmann T, Ritchlin C, et al. An 11-color flow cytometric assay for identifying, phenotyping, and assessing endocytic ability of peripheral blood dendritic cell subsets in a single platform. J Immunol Methods. 2009;341:106-16 pubmed publisher